SFX by Ex Libris Inc.

Title:	Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
Source:	Nature Medicine [1078-8956] Mayers, Jared yr:2014

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ge, D. "Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance." Nature 461.7262 (2009): 399-401.
description	2.	Muranen, T. "Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells." Cancer cell 21.2 (2012): 227-239.
description	3.	Biolo, G. "Response of muscle protein and glutamine kinetics to branched-chain-enriched amino acids in intensive care patients after radical cancer surgery." Nutrition 22.5 (2006): 475-82.
description	4.	Baracos, V. "Investigations of branched-chain amino acids and their metabolites in animal models of cancer." The Journal of nutrition 136.1 Suppl (2005): 237-42.
description	5.	Torchilin, Vladimir P. "New Synthetic Amphiphilic Polymers for Steric Protection of Liposomes in Vivo." Journal of pharmaceutical sciences 84.9 (1995): 1049-53.
description	6.	Thomas, David L. "Genetic variation in IL28B and spontaneous clearance of hepatitis C virus." Nature 461.7265 (2009): 798-801.
description	7.	Suppiah, V. "IL28B is associated with response to chronic hepatitis C interferon-Î± and ribavirin therapy." Nature Genetics 41.10 (2009): 1100-4.
description	8.	Brugge, Joan S. "Outgrowth of single oncogene-expressing cells from suppressive epithelial environments." Nature 482.7385 (2012): 410-413.
description	9.	Rauch, A. "Genetic variation in IL28B Is Associated with Chronic Hepatitis C and Treatment Failure - A Genome-Wide Association Study." Gastroenterology 138.4 (2010): 1338-1345.
description	10.	Iadonato, Shawn P. "Genomics: Hepatitis C virus gets personal." Nature 461.7262 (2009): 357-358.
description	11.	Lawitz, E. "Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection." New England Journal of Medicine, The 361.6 (2009): 580-593.
description	12.	Xue, P. "BCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal Cancer." EBioMedicine 20.C (2017): 50-60.
description	13.	O'Connell, Thomas M. "The complex role of branched chain amino acids in diabetes and cancer." Metabolites 3.4 (2013): 931-45.
description	14.	Bitterman, Peter B. "Attacking a Nexus of the Oncogenic Circuitry by Reversing Aberrant eIF4F-Mediated Translation." Molecular cancer therapeutics 11.5 (2012): 1051-1061.
description	15.	Oehler, R. "Hypothesis: Muscular glutamine deficiency in sepsis--a necessary step for a hibernation-like state?" Nutrition 26.5 (2010): 571-574.
description	16.	קירש, י. מבוא מתמטי, קינמטיקה, וקטורים, חוקי ניוטון, כבידה, סטטיסטיקה.
description	17.	Weigelt, Mina W. "HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment." Breast Cancer Research and Treatment 122.1 (2009): 35-43.
description	18.	Bizani, M. K. "Comparison of two methods, the thermodilution method of Fick and the Douglas bag method, in estimating the resting energy expenditure (REE)." Nutrition Research 15.12 (1995): 1747-1754.
description	19.	Hornberg, Jorrit J J. "Control of MAPK signalling: from complexity to what really matters." Oncogene 24.36 (2005): 5533-42.
description	20.	Kretschmer, K. "A METHOD TO MEASURE CRITICAL DETERGENT PARAMETERS PREPARATION OF LIPOSOMES." Analytical biochemistry 133.2 (1983): 486-91.